Jean M. Whaley

5.8k citations

32 papers · 3.7k indexed · 2 hit papers · h-index 22

Molecular Biology top 5%
Endocrinology, Diabetes and Metabolism top 0.5%
Surgery top 2%
Cancer Research top 2%
Oncology top 5%

Co-authors: Scott C. Thomson Volker Vallon Timo Rieg Deborah Hagan Nikolai Kley James F. List David N. Louis Richard Y. Chung
Topics: Diabetes Treatment and Management (16 papers)Pancreatic function and diabetes (12 papers)Metabolism, Diabetes, and Cancer (9 papers)
Cited by: Endocrinology, Diabetes and Metabolism Cancer Research Nephrology
Journals: Proceedings of the National Academy of Sciences Molecular Cell Diabetes
Partner nations: United States Germany United Kingdom

In The Last Decade

Jean M. Whaley

32 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule

2010 446 citations Volker Vallon, Kenneth A. Platt et al. Journal of the American Society of Nephrology profile →
The von Hippel-Lindau Tumor Suppressor Protein Is Required for Proper Assembly of an Extracellular Fibronectin Matrix

1998 395 citations Michael Ohh, Robert L. Yauch et al. Molecular Cell profile →

Peers

Countries citing papers authored by Jean M. Whaley

Since Specialization

Citations

This map shows the geographic impact of Jean M. Whaley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean M. Whaley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean M. Whaley more than expected).

Fields of papers citing papers by Jean M. Whaley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean M. Whaley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean M. Whaley. The network helps show where Jean M. Whaley may publish in the future.

Co-authorship network of co-authors of Jean M. Whaley

This figure shows the co-authorship network connecting the top 25 collaborators of Jean M. Whaley. A scholar is included among the top collaborators of Jean M. Whaley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean M. Whaley. Jean M. Whaley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unique pharmacology of a novel allosteric agonist/sensitizer insulin receptor monoclonal antibody 2018 ·Molecular Metabolism ·Simon A. Hinke,(unknown),Thomas Kirchner,Katharine D’Aquino,Rupesh Nanjunda,Jason Aligo,Robert A. Perkinson,Philip Cooper,(unknown),Mark L. Chiu,(unknown),Eilyn R. Lacy,Yin Liang,Dana L. Johnson,Jean M. Whaley,Russell B. Lingham,Anthony J. Kihm	12
2	SGLT2 knockout prevents hyperglycemia and is associated with reduced pancreatic β-cell death in genetically obese mice 2018 ·Islets ·Michael J. Jurczak,(unknown),(unknown),(unknown),(unknown),Xiaojian Zhao,Jean M. Whaley,Richard G. Kibbey	11
3	Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus 2014 ·Diabetes Therapy ·Timothy P. Reilly,Michael J. Graziano,Evan B. Janovitz,(unknown),Craig R. Fairchild,Francis Lee,Jian Chen,Tai‐Tong Wong,Jean M. Whaley,Mark A. Tirmenstein	55
4	Targeting Renal Glucose Reabsorption for the Treatment of Type 2 Diabetes Mellitus Using the SGLT2 Inhibitor Dapagliflozin 2012 ·Postgraduate Medicine ·Serge Jabbour,Jean M. Whaley,Mark A. Tirmenstein,Simon M. Poucher,Timothy P. Reilly,David W. Boulton,(unknown),James F. List,Shamik Parikh	12
5	Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus 2012 ·Diabetes Metabolic Syndrome and Obesity ·Jean M. Whaley,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	52
6	Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat 2011 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Scott C. Thomson,Timo Rieg,Cynthia M. Miracle,(unknown),Jean M. Whaley,Volker Vallon,Prabhleen Singh	239
7	Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans 2011 ·Kidney International ·James F. List,Jean M. Whaley	147
8	Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members 2010 ·Diabetes Therapy ·Jian Chen,Sandy Williams,Samantha Ho,(unknown),Deborah Hagan,Jean M. Whaley,John N. Feder	250
9	The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats 2010 ·Diabetes Obesity and Metabolism ·(unknown),(unknown),H. B. Jones,R.M. Mayers,(unknown),Jean M. Whaley,Simon M. Poucher	74
10	SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubulebreakdown → 2010 ·Journal of the American Society of Nephrology ·Volker Vallon,Kenneth A. Platt,Robyn Cunard,Jana Schroth,Jean M. Whaley,Scott C. Thomson,Hermann Koepsell,Timo Rieg	446
11	Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGLT2 2008 ·Bioorganic & Medicinal Chemistry Letters ·Bruce A. Ellsworth,Wei Meng,Manorama M. Patel,(unknown),Gang Wu,Philip M. Sher,Deborah Hagan,Mary T. Obermeier,W. Griffith Humphreys,James G. Robertson,Aiying Wang,Song‐Ping Han,Thomas L. Waldron,Nathan Morgan,Jean M. Whaley,William N. Washburn	43
12	Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity 1999 ·Oncogene ·(unknown),Joseph G. Naglich,Jean M. Whaley,Bernd R. Seizinger,Nikolai Kley	108
13	The von Hippel-Lindau Tumor Suppressor Protein Is Required for Proper Assembly of an Extracellular Fibronectin Matrixbreakdown → 1998 ·Molecular Cell ·Michael Ohh,Robert L. Yauch,Kim M. Lonergan,Jean M. Whaley,Anat Stemmer‐Rachamimov,David N. Louis,Brian Gavin,Nikolai Kley,William G. Kaelin,Othon Iliopoulos	395
14	Neurofibromatosis type 2 and von Hippel‐Lindau disease: From gene cloning to function 1995 ·Glia ·Nikolai Kley,Jean M. Whaley,(unknown)	8
15	Germline mutations in the VHL tumor suppresssor gene are similar to somatic VHL aberrations in sporadic renal cell carcinoma 1994 ·The American Journal of Human Genetics ·Jean M. Whaley,Joseph G. Naglich,Lawrence M. Gelbert	1
16	Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors 1993 ·Journal of Neuropathology & Experimental Neurology ·David N. Louis,Andreas von Deimling,Richard Y. Chung,Mari‐Paz Rubio,Jean M. Whaley,Robert H. Eibl,Hiroko Ohgaki,Otmar D. Wiestler,Ann D. Thor,Bernd R. Seizinger	195
17	Cytogenetic and molecular studies of a familial renal cell carcinoma 1992 ·Cancer Genetics and Cytogenetics ·(unknown),Bernd Wullich,Jean M. Whaley,Guillermo A. Herrera,Sabine M. Klauck,Avery A. Sandberg,David W. Yandell,Bernd R. Seizinger	6
18	TP53 Gene Mutations and 17p Deletions in Human Astrocytomas 1991 ·Genes Chromosomes and Cancer ·Richard Y. Chung,Jean M. Whaley,Nikolai Kley,(unknown),David N. Louis,Anil G. Menon,(unknown),Richard N. Freiman,E. Tessa Hedley‐Whyte,Robert L. Martuza,Robert B. Jenkins,David W. Yandell,(unknown)	118
19	Mutation Induction by ¹²⁵ iodoacetylproflavine, a DNA-intercalating Agent, in Human Cells 1990 ·International Journal of Radiation Biology ·Jean M. Whaley,Amin I. Kassis,Berma M. Kinsey,S. James Adelstein,John B. Little	9
20	Molecular characterization of hprt mutants induced by low- and hgh-LET radiations in human cells 1990 ·Mutation Research Letters ·Jean M. Whaley,John B. Little	43

About Jean M. Whaley

Jean M. Whaley is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Oncology, having authored 32 papers that have together received 3.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (16 papers), Pancreatic function and diabetes (12 papers) and Metabolism, Diabetes, and Cancer (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Cancer Research (778 citations) and Nephrology (289 citations). Jean M. Whaley has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Scott C. Thomson, Volker Vallon, Timo Rieg, Deborah Hagan, Nikolai Kley, James F. List, David N. Louis, Richard Y. Chung, Bernd R. Seizinger and Kenneth A. Platt. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular Cell and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact